Article
Short-term results of Revision Cubital Tunnel Release Treated With Neurolysis and Procine Submucosa Extracellular Matrix
Search Medline for
Authors
Published: | February 6, 2020 |
---|
Outline
Text
Objectives/Interrogation: Epineural scarring following decompression of a peripheral nerve results in significant morbidity. We report a single institution experience of using procine submucosa extracellular matrix (AxoGuardŽ AxoGen Inc., Alachua FL) in revision Cubital tunnel release.
Methods: Twenty-four patients with recurrent ulnar nerve compression neuropathy at the elbow were treated with revision cubital tunnel release, neurolysis and AxoGuardŽ nerve wrapping. Idiopathic cubital tunnel syndrome was the primary operation in 16 cases and 9 had primary ulnar decompression following elbow trauma. Patient demographics, pre-and post-operative pain scores, sensory function, Tinel's sign and patient satisfaction were recorded in each case.
Results and Conclusions: All patients were followed up to an average of 6 months (range 3-40), mean age of patients 50 was years (range 27-75). Post-operative pain levels improved from 7 to 3 (p<0.05) and sensation improved from a mean of 4 to 8. Following revision surgery absence of Tinel's sign was noted in 18 patients. One case had early re-exploration due to a wound haematoma. There were no complications associated with the use of the porcine submucosa extracellular matrix as a nerve wrap.
In this series of revision cubital tunnel decompression and neurolysis the addition of an AxoGuardŽ demonstrated good clinical results with no complications.